摘要
KK- Ay糖尿病(DM)小鼠分别接受格列美脲(GM)和格列本脲(GB)治疗,治疗后GM组的腹腔白色脂肪含量、血清胰岛素及下丘脑神经肽Y(NPY)水平的增加幅度均显著小于GB组,提示格列美脲治疗2型DM时体脂增加较少除因GM刺激的胰岛素水平较低以外,也可能与GM对下丘脑NPY合成释放的作用较弱有关。
Diabetic KK-Ay mice were given glimepiride (GM) and glibenclamide (GB). After treatment, the visceral white fat content, insulin and hypothalamic neuropeptide Y (NPY) levels were significantly lower in GM group than those in GB group, suggesting that in addition to the lower insulin level stimulated by GM, the lower concentration of hypothalamic NPY seems to play a role in lessening increase in body fat of type 2 diabetic animals treated with GM.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2005年第2期167-168,共2页
Chinese Journal of Endocrinology and Metabolism